中国血液净化

中国血液净化 ›› 2024, Vol. 23 ›› Issue (01): 1-8.doi: 10.3969/j.issn.1671-4091.2024.01.001

• 共识与指南 •    下一篇

2023年美国血液分离学会“治疗性血液分离技术临床实践指南”(第9版)解读

万 利    王 梅   

  1. 102206 北京，1北京大学国际医院肾脏内科血液净化中心
    100044 北京，2北京大学人民医院肾内科
  • 收稿日期:2023-08-22 修回日期:2023-09-29 出版日期:2024-01-12 发布日期:2024-01-12
  • 通讯作者: 王梅 E-mail:wangmei1949@163.com

Interpretation on the 2023 clinical practice guidelines of plasma component purification technology from the American Society for Apheresis (9th edition) 

WAN Li,  WANG Mei   

  1. Blood Purification Center, Department of Nephrology, Peking University International Hospital, Beijing 102206, China; 2Department of Nephrology, Peking University People's Hospital, Beijing 100044, China
  • Received:2023-08-22 Revised:2023-09-29 Online:2024-01-12 Published:2024-01-12
  • Contact: 100044 北京，2北京大学人民医院肾内科 E-mail:wangmei1949@163.com

PDF

18

摘要： 2023年4月美国血液分离学会(American Society for Apheresis，ASFA)发布了第9版《治疗性血液分离技术临床实践指南》。该指南基于目前已发表的文献，确定治疗性血液分离技术治疗疾病的证据质量及推荐强度，讨论了该技术在91种疾病(166种适应证)中的临床应用。本文重点解读血浆净化技术，即血浆置换和免疫吸附技术在临床多学科中的应用。

关键词: 血液分离技术, 血浆置换, 免疫吸附, 临床实践指南

Abstract:  In April 2023, the American Society for Apheresis (ASFA) released the 9th edition of guidelines for clinical practice of therapeutic apheresis. Based on published literature, these guidelines define the quality of evidence and the recommended strength of therapeutic apheresis in the treatment of diseases, and discuss the clinical application of therapeutic apheresis in 91 disease (166 indications). This article focuses on the interpretation of clinical multidisciplinary applications of plasma component purification technology, including plasma exchange and immuneadsorption.

Key words: Apheresis, Plasma exchange, Immunoadsorption, Clinical practice

中图分类号: